Skip to content

Effect of intraarterial lidocaine on post uterine fibroma embolization pain

The evaluation of intraarterial lidocaine injection during uterine artery embolization on the reduction of post-embolization pain

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220126053835N1
Enrollment
50
Registered
2022-08-08
Start date
2022-07-06
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-uterine artery embolization pain.

Interventions

Intervention 1: Intervention group: The patients will be sedated with 5 mg midazolam and the embolization process will be initiated. The standard embolization protocol will be applied in which a 5 f c

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patients with confirmed leiomyoma by ultrasonography Being in the childbearing ages Being the candidate of uterine artery embolization according to the opinion of obstetrician and gynecology specialist

Exclusion criteria

Exclusion criteria: The patients with medical history of hypersentivity to pethidine, morphine, lidocaine and contrast agents The history of cardiac arrhythmia The presence of active pelvic inflammatory disease

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: 2, 4, 6 and 8 hours after the operation. Method of measurement: Visual Analogue Scale.;The applied pethidine dosage for pain controlling. Timepoint: 2, 4, 6 and 8 hours after the operaion. Method of measurement: According to the medical records (mg).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Tabibian

Esfahan University of Medical Sciences

srt_1371@yahoo.com+98 31 3250 6157

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026